Share
Publications
-
15 December 2009 /Prices and reimbursement
Considerable increase in consumption of antidiabetic drugs from 1999 to 2008 in Denmark
The number of people in Denmark being diagnosed with diabetes has soared for the past many years, and the same can be said for the sums spent on treatment and medicines for antidiabetics.
-
13 July 2009 | Updated 27 August 2009 /Prices and reimbursement
Effective effort against the excessive use of benzodiazepines in Denmark
A long-term use of sleeping medicine and anti-anxiety drugs of the benzodiazepine type should be avoided, as it can lead to addiction, dizziness, memory impairment and concentration difficulties, as well as an increased risk of falling. Throough the years, many political health care initiatives have therefore been launched in order to reduce the consumption of these medicines.
-
28 April 2009 /Prices and reimbursement
-
01 December 2009 /Prices and reimbursement
Sale of dose dispensed medicine in the primary Danish health sector 2004-2008
Dose dispensing was launched in Denmark in 2002, and the use of dose dispensing has increased since then. Dose dispensing is used by all age groups, but the share of users increases with age, and women more frequently use dose dispensed medicine than men.
-
17 June 2009 /Prices and reimbursement
Sale of liberalised OTC medicines from 2001-2007
The liberalisation of over-the-counter products (OTC medicines) may have contributed to an increase in the sale of smoking cessation products in the period from 2001-2007. With regard to the remaining medicinal products, there is nothing to suggest that the sale in general sales outlets has led to increased consumption.
-
17 June 2009 /Prices and reimbursement
Use of prescription weight-loss products from 2003-2007
In recent years, the number of persons treated with prescription-only weight-loss products has increased, however, the total number of persons receiving treatment is lower than before 2002. The weight-loss products are primarily used by women aged between 35-55. In 2007, the number of users was affected by seasonal variations, which are more pronounced if we exclude persons who at the same time receive other medicines associated with overweight.
